Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 63
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

Searching for Genetic Clues in Autism with Family Trio Sequencing

Autism is a complex condition, but recent research shows that genetics may play a larger role than previously...

Mathematical model to reduce maternal and infant mortality in Southeast Asia

Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

Backer Badge Funded